Marksans Pharma Ltd. Conference Calls and Earnings Call Transcripts

31 May 2023, 06:44PM

168.60

-0.51%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement Under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the aforesaid Financial Results Conference Call is hosted on the website of the Company under the following link: http://marksanspharma.com/investors-meet.html

pdf

Marksans Pharma Ltd.

21 Feb 2023

168.60

-0.51%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Q3 FY23 Earnings Conference Call held on February 14, 2023

pdf

Marksans Pharma Ltd.

14 Feb 2023

168.60

-0.51%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

pdf

Marksans Pharma Ltd.

14 Feb 2023

168.60

-0.51%

Marksans Pharma Results Earnings Call for Q3FY23

Conference Call with Marksans Pharma Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.

Marksans Pharma Ltd.

21 Nov 2022

168.60

-0.51%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Q2 FY23 Earnings Conference Call held on November 16, 2022.

pdf

Marksans Pharma Ltd.

16 Nov 2022

168.60

-0.51%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the Q2FY23 & H1FY23 Results Conference Call is hosted on the website of the Company under the following link: http://marksanspharma.com/investors-meet.htmI

pdf

Marksans Pharma Ltd.

19 Aug 2022

168.60

-0.51%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Q1FY23 Earnings Conference Call held on August 16, 2022.

pdf

Marksans Pharma Ltd.

17 Aug 2022

168.60

-0.51%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio recording of Q1FY23 Results Conference Call is hosted on the website of the Company at http://marksanspharma.com/investors-meet.html

pdf

Marksans Pharma Ltd.

06 Jun 2022

168.60

-0.51%

Earnings Call

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Q4 &FY22 Earnings Conference Call held on June 1, 2022.

pdf

Marksans Pharma Ltd.

01 Jun 2022

168.60

-0.51%

Earnings Call for Q4FY22 of Marksans Pharma

Conference Call with Marksans Pharma Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.

Marksans Pharma Ltd. Conference Calls and Earnings Call Transcripts